SORT BY

FILTER BY

also on other fortune lists

company facts

f500 stats

Fortune 500

Courtesy of Boston Scientific

328

Boston Scientific

BSX

Boston Scientific makes medical devices that treat and diagnose medical conditions, including heart disease and chronic pain.

Looking for leads, investment insights, or competitive intelligence?

CEO

Michael F. Mahoney

CEO Title

Chairman, President & Chief Executive Officer

Sector

Health Care

Industry

Medical Products and Equipment

HQ Location

Marlborough, Mass.

Years on Fortune 500 List

15

Employees

29,000

Key Financials (Last Fiscal Year)
$ millions% change
Revenues ($M)$9,0487.9%
Profits ($M)$104.0-70.0%
Assets ($M)$19,042
Total Stockholder Equity ($M)$7,012
Market Value — as of March 29, 2018 ($M)$37,688
Profit Ratios
Profit as % of Revenues1.1%
Profits as % of Assets0.5%
Profits as % of Stockholder Equity1.5%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)0.08
EPS % Change (from 2016)-68.0%
EPS % Change (5 year annual rate)-
EPS % Change (10 year annual rate)-
Total Return
Total Return to Investors (2017)14.6%
Total Return to Investors (5 year, annualized)34.0%
Total Return to Investors (10 year, annualized)7.9%
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about Boston Scientific

4 'Buyback' Stocks Worth Buying

Big share repurchases can be a bad deal for investors, but these stocks have been an exception.

Read More →
Penumbra goes public tomorrow. Hear from its CEO today

The medical device maker will have a very special guest help ring tomorrow's opening bell at the NYSE.

Read More →